Joshi Apurva Kumar R, Rajini P S
Food Protectants and Infestation Control Department, Central Food Technological Research Institute (CSIR Laboratory), Mysore 570020, India.
Toxicology. 2009 Mar 4;257(1-2):40-5. doi: 10.1016/j.tox.2008.12.006. Epub 2008 Dec 11.
The present study was undertaken to investigate the hyperglycemic potential of acute exposure to acephate and its etiology employing rat model system. Oral administration of acephate (140mg/kg b.w.) caused reversible hyperglycemia as evidenced by peak increase in blood glucose at 2h after the administration (87% over control) followed by trend of normalization. In further experiment carried out to understand the etiology of the induced hyperglycemia, we observed that 2h exposure to acephate caused significant increase in blood glucose, plasma corticosterone (78%) and activities of two gluconeogenesis enzymes in liver viz., glucose-6-phosphatase (91%) and tyrosine aminotransferase (84%) compared to that in control. When rats were exposed to acephate for 6h, decrement was observed in elevated levels of blood glucose, plasma corticosterone and the gluconeogenesis enzymes of the liver. Adrenal cholesterol levels in acephate-exposed rats were significantly depleted. While the glycogen content in liver of 2-h exposure group was comparable to control, a tremendous increase in liver glycogen content ( approximately 3.5 folds) was observed in rats of the 6-h exposure group. Our results demonstrate that acephate causes reversible hyperglycemia in rats probably by enhancing hepatic glucose output via gluconeogenesis. A role for hyperactivity of adrenal cortex is suggested in increased gluconeogenesis while significant attenuation in elevated levels of blood glucose and the activity the gluconeogenesis enzyme, glucose-6-phosphatase in liver with concomitant increase in liver glycogen are indicative of the onset of counter-regulatory responses such as hyperinsulinemia, to overcome the induced hyperglycemia.
本研究旨在利用大鼠模型系统研究急性接触乙酰甲胺磷的高血糖潜力及其病因。口服乙酰甲胺磷(140mg/kg体重)导致可逆性高血糖,给药后2小时血糖峰值升高(比对照组高87%),随后有恢复正常的趋势,这证明了这一点。在进一步的实验中,为了了解诱导性高血糖的病因,我们观察到,与对照组相比,接触乙酰甲胺磷2小时导致血糖、血浆皮质酮显著升高(78%),肝脏中两种糖异生酶即葡萄糖-6-磷酸酶(91%)和酪氨酸转氨酶(84%)的活性显著升高。当大鼠接触乙酰甲胺磷6小时后,观察到血糖、血浆皮质酮和肝脏糖异生酶的升高水平有所下降。接触乙酰甲胺磷的大鼠肾上腺胆固醇水平显著降低。虽然2小时接触组肝脏中的糖原含量与对照组相当,但在6小时接触组的大鼠中观察到肝脏糖原含量大幅增加(约3.5倍)。我们的结果表明,乙酰甲胺磷可能通过糖异生增强肝脏葡萄糖输出,从而导致大鼠出现可逆性高血糖。肾上腺皮质功能亢进在糖异生增加中起作用,而血糖升高水平和肝脏糖异生酶葡萄糖-6-磷酸酶活性的显著降低,同时肝脏糖原增加,表明出现了诸如高胰岛素血症等反调节反应,以克服诱导性高血糖。